Evidence map›Paper›PMID 39944484›Full record

ArticleFrontiers in medicine2025

Development of a prognostic nomogram for ocular melanoma: a SEER population-based study (2000-2021).

Miyun Zheng, Maodong Xu, Mengxing You, Zhiqing Huang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Miyun ZhengDepartment of Ophthalmology, The First Hospital of Putian City, Putian, China.
Maodong XuDepartment of Ophthalmology, The First Hospital of Putian City, Putian, China.
Mengxing YouThe School of Clinical Medicine, Fujian Medical University, Fuzhou, China.
Zhiqing HuangDepartment of Ophthalmology, The First Hospital of Putian City, Putian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Ocular melanoma (OM) is a rare but lethal subtype of melanoma. This study develops a prognostic nomogram for OM using machine learning and internal validation techniques, aiming to improve prognosis prediction and clinical decision-making. Methods: Independent prognostic variables were identified using univariate and multivariate COX proportional hazard regression models. Significant variables were then incorporated into the nomogram. The predictive accuracy of the nomogram was evaluated using receiver operating characteristic (ROC) curves, calibration plots, decision curve analysis (DCA), and 10-fold cross-validation. The performance of the nomogram was compared with that of a machine learning model. Results: Thirteen variables, including age, sex, tumor site, histologic subtype, stage, basal diameter size, tumor thickness, liver metastasis, first malignant primary indicator, marital status, and treatment modalities (surgery/radiotherapy/chemotherapy) were identified as independent prognostic factors for overall survival (OS) and were included in the nomogram (all Conclusions: A robust nomogram incorporating 13 significant clinicopathological variables was developed. The combined use of ROC curve analysis, calibration plots, DCA, 10-fold cross-validation, and machine learning confirmed the strong predictive performance of the nomogram for survival outcomes in patients with OM.

Indexed as

machine learningnomogramocular melanomaprognosisSEERSHAP

Identifiers

PMID39944484
PMCPMC11813910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.